One (non-demonstrated) hypothesis is that somatic mutations in cancer cells may have occurred in the TIF1γ gene, yielding to the production of an immunogenic non-self neoantigen, which could lead to autoimmunity after epitope spreading of the B cell response, following the example of POLR3 mutations in systemic sclerosis (34). The gene discussed is TRIM33; the disease is cancer.